febuxostat has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amirshahrokhi, K | 1 |
| Abu-Risha, SE; Amer, MS; El-Mahdy, NA; Saleh, DA | 1 |
2 other study(ies) available for febuxostat and Colitis Gravis
| Article | Year |
|---|---|
Febuxostat attenuates ulcerative colitis by the inhibition of NF-κB, proinflammatory cytokines, and oxidative stress in mice.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Colitis, Ulcerative; Colon; Cytokines; Febuxostat; Glutathione; Male; Malondialdehyde; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide; Oxidative Stress; Peroxidase; Superoxide Dismutase; Xanthine Oxidase | 2019 |
Role of allopurinol and febuxostat in the amelioration of dextran-induced colitis in rats.
Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Dextran Sulfate; Drug Therapy, Combination; Febuxostat; Glutathione; Interleukin-1beta; Interleukin-6; Male; Malondialdehyde; Rats, Wistar; Sulfasalazine; Superoxide Dismutase; Uric Acid; Xanthine Oxidase | 2020 |